Macrogenics Inc (MGNX)
3.21
-0.07
(-2.13%)
USD |
NASDAQ |
Nov 21, 16:00
3.39
+0.18
(+5.61%)
After-Hours: 20:00
Macrogenics Profit Margin (Quarterly): 50.86% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 50.86% |
| June 30, 2024 | -515.6% |
| March 31, 2024 | -573.3% |
| December 31, 2023 | -502.7% |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | -155.2% |
| December 31, 2022 | 17.99% |
| September 30, 2022 | -59.46% |
| June 30, 2022 | -158.8% |
| March 31, 2022 | -622.5% |
| December 31, 2021 | -470.1% |
| September 30, 2021 | -337.7% |
| June 30, 2021 | -129.8% |
| March 31, 2021 | -319.0% |
| December 31, 2020 | -4.03% |
| September 30, 2020 | -207.0% |
| June 30, 2020 | -299.9% |
| March 31, 2020 | -344.9% |
| December 31, 2019 | -123.8% |
| September 30, 2019 | -248.2% |
| June 30, 2019 | -318.1% |
| March 31, 2019 | -474.0% |
| December 31, 2018 | -298.1% |
| September 30, 2018 | -165.1% |
| Date | Value |
|---|---|
| June 30, 2018 | -233.1% |
| March 31, 2018 | -1.10K% |
| December 31, 2017 | 69.52% |
| September 30, 2017 | -4.37K% |
| June 30, 2017 | -3.76K% |
| March 31, 2017 | -2.95K% |
| December 31, 2016 | -367.1% |
| September 30, 2016 | -1.68K% |
| June 30, 2016 | 51.55% |
| March 31, 2016 | -1.60K% |
| December 31, 2015 | -302.3% |
| September 30, 2015 | -105.2% |
| June 30, 2015 | -381.9% |
| March 31, 2015 | 63.41% |
| December 31, 2014 | -321.7% |
| September 30, 2014 | -21.48% |
| June 30, 2014 | -133.2% |
| March 31, 2014 | -21.58% |
| December 31, 2013 | -20.01% |
| September 30, 2013 | 32.84% |
| June 30, 2013 | -2.48% |
| March 31, 2013 | -33.44% |
| December 31, 2012 | -22.48% |
| September 30, 2012 | 16.74% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-622.5%
Minimum
Mar 2022
50.86%
Maximum
Sep 2024
-264.2%
Average
-253.4%
Median
Profit Margin (Quarterly) Benchmarks
| KORU Medical Systems Inc | -19.33% |
| Apellis Pharmaceuticals Inc | -29.19% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -77.40% |
| Return on Assets | -36.09% |
| Return on Invested Capital | -77.40% |
| Gross Profit Margin (Quarterly) | 98.31% |
| Operating Margin (Quarterly) | 48.95% |
| Return on Net Operating Assets | -169.9% |